Compare TASK & OVID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TASK | OVID |
|---|---|---|
| Founded | 2008 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 585.9M | 522.6M |
| IPO Year | 2021 | 2017 |
| Metric | TASK | OVID |
|---|---|---|
| Price | $6.13 | $2.44 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 5 | 5 |
| Target Price | ★ $14.70 | $4.60 |
| AVG Volume (30 Days) | 638.2K | ★ 1.8M |
| Earning Date | 05-06-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 120.00 | 3.90 |
| EPS | ★ 0.26 | N/A |
| Revenue | N/A | ★ $7,252,000.00 |
| Revenue This Year | $5.95 | N/A |
| Revenue Next Year | $6.46 | $19.34 |
| P/E Ratio | $23.13 | ★ N/A |
| Revenue Growth | N/A | ★ 1181.27 |
| 52 Week Low | $5.39 | $0.27 |
| 52 Week High | $18.39 | $3.11 |
| Indicator | TASK | OVID |
|---|---|---|
| Relative Strength Index (RSI) | 44.42 | 39.87 |
| Support Level | N/A | $1.23 |
| Resistance Level | $6.97 | $2.72 |
| Average True Range (ATR) | 0.40 | 0.17 |
| MACD | 0.08 | -0.06 |
| Stochastic Oscillator | 47.15 | 15.15 |
TaskUs Inc provides outsourced digital services. Its service offerings include Digital Customer Experience consists of omnichannel customer care services, delivered through digital (non-voice) channels, also including learning experience and sales and customer acquisition services; Trust & Safety consists of monitoring, reviewing and managing user and advertiser-generated content on online platforms to ensure it complies with community guidelines, legal regulations and platform specific policies; and AI Services consists of large language model support and high-quality data labeling services, annotation, context relevance and transcription services performed for the purpose of training and tuning machine learning algorithms, enabling them to develop cutting-edge AI systems.
Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.